| Orders | Qty | Bid |
|---|---|---|
| 3 | 201 | 816.65 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
MedPlus Health Services Limited, incorporated on November 30, 2006, is a leading organised retail pharmacy chain in India with an omnichannel model spanning neighbourhood stores and digital platforms. Its portfolio includes pharmaceuticals, wellness items, and FMCG such as OTC medicines, vitamins, medical devices, toiletries, baby care, soaps, detergents, and sanitizers. As of March 31, 2025, operations spanned 13 states and 1 union territory across 700 cities with 4,712 stores, supported by a cluster-based expansion strategy and technology-driven supply chain. The company reported revenue from operations of Rs 6,136.05 crore in FY 2024-25 and PAT of Rs 150.23 crore. MedPlus launched MedPlus-branded pharmaceutical products covering acute and chronic therapies, which reached GMV of H 14,025.52 million (reported as a share of pharmacy revenues) in FY 2024 on a GMV basis, aligning with its focus on quality and affordability. Optival Health Solutions Private Limited is identified as a material subsidiary; exports contribute 0% of turnover. Operations are national, with no international offices.

No,Medplus Health Services Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹818.10, the trailing dividend yield of Medplus Health Services Ltd stands at N/A%.
Medplus Health Services Ltd has delivered a -26.67% absolute return over the past 5 years, equivalent to a CAGR of -6.02% per annum. The stock was priced at ₹1,115.64 in Jul 2021 and has fallen to ₹818.10 as of 07 Jul 2026. An investment of ₹1,00,000 in Medplus Health Services Ltd five years ago would be worth ₹73,330.00 today.
The all-time high (ATH) for Medplus Health Services Ltd was ₹1,290.00, recorded on 20 Jan 2022. At the current price of ₹818.10, the stock is trading 36.58% below its all-time high. The all-time low recorded was ₹576.30 on 09 Nov 2022.
Medplus Health Services Ltd has delivered -4.46% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,022.20 on 21 May 2026 and a 52-week low of ₹732.00 on 03 Oct 2025. It is currently trading at ₹818.10 as of 07 Jul 2026.
The intraday low for Medplus Health Services Ltd on the NSE today was ₹815.60. The stock's 52-week low stands at ₹732.00, recorded on 03 Oct 2025. Today's low is 11.42% above the 52-week low, indicating the stock is trading well above its yearly lows.
For Q4 FY26, Medplus Health Services Ltd reported: Revenue (Net Sales): ₹2480.36 Cr - Up 11.23% year-on-year from ₹2230.01 Cr in Q3 FY26. Net Income (PAT): ₹166.72 Cr - Up 0.58% year-on-year from ₹165.76 Cr in Q3 FY26.
Medplus Health Services Ltd has delivered a return of -2.50% over the last 3 months. The stock was trading at ₹843.25 on 07 Apr 2026 and is currently at ₹818.10 as of 07 Jul 2026, reflecting a Loss of ₹25.15 per share over this period.
As of 07 Jul 2026, the share price of Medplus Health Services Ltd is ₹818.10 on the NSE and ₹818.00 on the BSE. The stock opened at ₹822.00, touched a high of ₹830.00 and a low of ₹815.60 during today's session.
Over the last 6 months, Medplus Health Services Ltd has given a return of -1.40%. The stock was priced at ₹833.80 on 07 Jan 2026 and has Fallen to ₹818.10 as of 07 Jul 2026, a change of ₹15.70 per share.
The intraday high for Medplus Health Services Ltd on the NSE today (07 Jul 2026) was ₹830.00. This compares to the 52-week high of ₹1,022.20 recorded on 21 May 2026. Today's high was -18.80% below the 52-week high.